AssessmentsRestrictive lung diseases
Restrictive lung diseases
USMLE® Step 1 style questions USMLE
USMLE® Step 2 style questions USMLE
A 67-year-old man with a history of cigarette smoking presents to his family doctor with progressive shortness of breath and cough. He came in three months ago with similar symptoms and was started on treatment with bronchodilators for a presumed diagnosis of chronic obstructive pulmonary disease (COPD). His past medical history is only significant for rheumatoid arthritis, for which he takes methotrexate. On examination, there are bibasilar crackles and finger clubbing. The patient’s pulmonary function tests from 30-years-ago are shown below:
Which of the following pulmonary function test findings is now most likely?
Content Reviewers:Charles Davis, MD
Restrictive lung diseases are just as they sound, restrictive.
There are two types of restrictive lung diseases, interstitial and extra-pulmonary.
For the interstitial type, it refers to the lung tissue itself being damaged.
Imagine a lung being hard and stiff like tough rubber, that lung tissue won’t easily allow air to enter during inhalation, thereby reducing the lung volume.
In the extra-pulmonary type, the structures around the lung are damaged and that prevents chest expansion.
Think about how hard it would be to take a breath when you have someone sitting on your chest.
During inhalation, both the diaphragm and intercostal muscles located in between your ribs contract to pull the ribs up and out and expand the chest cavity. This creates a vacuum which pulls the lungs open.
Between the alveoli, there’s connective tissue made up of proteins like elastin fibers, which give the lungs their rubber-band like properties, and collagen, which gives the lungs their firmness and their overall shape.
During exhalation, both the diaphragm and the intercostal muscles relax to allow the chest wall to fall and return the chest cavity back to normal.
At the same time, the elastin and collagen fibers in the interstitium allow the lung to spring back and push the air back out.
There are a number of ways to measure the volume of air as it is inhaled and exhaled from the lungs.
For example, total lung capacity is the total amount of air that the lungs can hold.
Tidal volume is the volume of air inhaled during normal inhalation and the functional residual capacity is the total amount of air left in the lungs after a normal exhalation.
There’s also the forced vital capacity, or FVC, which is the maximum amount of air exhaled after a full inhalation, and the forced expiratory volume in one second, or FEV1, which is the amount of air forcibly breathed out in one second after a maximum inhalation.
The normal ratio of FEV1 to FVC is 0.8, meaning that 80% of the air should be able to get forced out in the first second.
In interstitial restrictive lung diseases, the lung tissue gets damaged in various ways.
The first large category of these diseases is called pneumoconiosis, which is a broad category that includes the diseases that result from occupational exposures.
Coal workers’ pneumoconiosis occurs in coal miners who inhale tiny particles of coal or carbon dust which mainly settle in small airways in the upper lobes of the lung.
Silicosis is another type of pneumoconiosis which occurs in silica miners and sandblasters who inhale silica particles which also settle in the upper lobes of the lung.
A third type of pneumoconiosis is asbestosis and that typically occurs in construction workers and shipyard workers because asbestos has been used in building materials for many years.
Often, asbestos fibers settle in the lower lobes and on the pleural membrane which surrounds the lung, forming white thick patches called pleural plaques.
All of these different particles - carbon dust, silica particles, and asbestos fibers - can cause an immune reaction to develop.
Fibroblasts then arrive on scene to try and repair the damage by depositing extracellular matrix composed of collagen.
- "Robbins Basic Pathology" Elsevier (2017)
- "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
- "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
- "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
- "Fishman's Pulmonary Diseases and Disorders, 2-Volume Set, 5th edition" McGraw-Hill Education / Medical (2015)
- "Diffuse Lung Disorders" Springer Science & Business Media (2012)
- "Dyspnea and Decreased Variability of Breathing in Patients with Restrictive Lung Disease" American Journal of Respiratory and Critical Care Medicine (2002)
- "Clinical Advances in the Diagnosis and Therapy of the Interstitial Lung Diseases" American Journal of Respiratory and Critical Care Medicine (2005)
- "Idiopathic non‐specific interstitial pneumonia" Respirology (2015)